Protagenic Therapeutics (NASDAQ:PTIX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Protagenic Therapeutics (PTIX) operate in?

Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Protagenic Therapeutics Stock (NASDAQ: PTIX) stock price, news, charts, stock research, profile.

Open	$0.60
Close	-
Volume / Avg.	648.40K / 172.35K
Day Range	$0.59 - $0.76
52 Wk Range	0.45 - 1.87
Market Cap	$4.74M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	1.68%
Days to Cover	1

Recent News

Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.60
Close	-
Volume / Avg.	648.40K / 172.35K
Day Range	$0.59 - $0.76
52 Wk Range	0.45 - 1.87
Market Cap	$4.74M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	59
Short Interest	1.68%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Protagenic Therapeutics (PTIX) stock?

You can purchase shares of Protagenic Therapeutics (NASDAQ:PTIX) through any online brokerage.

View our list of the best stock brokerages

Who are Protagenic Therapeutics (PTIX) competitors?

Other companies in Protagenic Therapeutics’s space includes: Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI), TransCode Therapeutics (NASDAQ:RNAZ) and Alaunos Therapeutics (NASDAQ:TCRT).

What is the forecast, or price target, for Protagenic Therapeutics (PTIX) stock?

There is no analysis for Protagenic Therapeutics to provide a consensus price target.

What is the current price for Protagenic Therapeutics (PTIX)?

The stock price for Protagenic Therapeutics (NASDAQ: PTIX) is $0.6979 last updated December 18, 2024 at 1:39 PM EST.

Does Protagenic Therapeutics (PTIX) pay a dividend?

There are no upcoming dividends for Protagenic Therapeutics.

When is Protagenic Therapeutics (NASDAQ:PTIX) reporting earnings?

Protagenic Therapeutics’s Q3 earnings are confirmed for Thursday, November 14, 2024.

Is Protagenic Therapeutics (PTIX) going to split?

There is no upcoming split for Protagenic Therapeutics.

What sector and industry does Protagenic Therapeutics (PTIX) operate in?

Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Protagenic Therapeutics

Protagenic Therapeutics (PTIX) Forecast